ST. LOUIS, MO. -- Bisphosphonates remain underutilized in the prevention of glucocorticoid-induced osteoporosis, despite the existence of national clinical guidelines that recommend their use in patients on long-term oral steroid therapy, Rosemarie Liu, M.D., said at the annual meeting of the ...

No Results Found.